Immunology in Celiac Disease

Area of Science:

• Immunology
• Genetics

Background:

• Celiac disease (CeD) is an autoimmune disorder strongly linked to human leukocyte antigen (HLA) DQ2 and DQ8.
• The presence of HLA-DQ2 or HLA-DQ8 is essential for CeD development, while their absence excludes the diagnosis.
• Specific suballeles of HLA-DQ2 and HLA-DQ8 influence the risk and presentation of CeD.

Purpose of the Study:

• To elucidate the role of human leukocyte antigen (HLA) DQ2 and DQ8 in celiac disease (CeD) pathogenesis.
• To highlight the immunogenic gliadin peptides influenced by HLA-DQ2 and DQ8.
• To identify key immune cells involved in CeD.

Main Methods:

• Review of recent publications focusing on CeD pathogenesis.
• Analysis of the association between HLA-DQ2/DQ8 and gliadin peptide immunogenicity.
• Identification of immune cell involvement, including T cells, antigen-presenting cells (APCs), B cells, and epithelial cells.

Main Results:

• The absence of HLA-DQ2 and/or DQ8 definitively rules out CeD diagnosis.
• HLA-DQ2 and DQ8 dictate the immunogenicity of specific gliadin peptides.
• Key immune players in CeD pathogenesis include T cells, APCs, B cells, and epithelial cells.

Conclusions:

• HLA-DQ2 and DQ8 are critical determinants in celiac disease susceptibility.
• Understanding the interaction between gliadin peptides and HLA variants is key to CeD pathogenesis.
• Further research is exploring the roles of specific immune cells like γδ T cells, mast cells, and eosinophils in CeD.